What is the treatment for mycoplasma pneumonia in children?

Mycoplasma pneumonia in children is a relatively common disease. Generally, this disease is more serious and its treatment time is relatively long. Therefore, we must pay attention to it during treatment and treat it in time. So what are the treatments for Mycoplasma pneumonia in children? I hope everyone can understand this phenomenon, so let’s take a look at it now.

(1) Respiratory tract isolation: Mycoplasma infection can cause small epidemics, and the time for children to excrete mycoplasma after becoming ill is long, up to 1 to 2 months. Infants only show symptoms of upper respiratory tract infection. Pneumonia occurs only after repeated infection. At the same time, it is easy to be infected with other viruses during the MP infection period, which may lead to worsening of the disease and prolonged illness. Therefore, respiratory isolation should be achieved as much as possible for children with the disease or children with a history of close contact to prevent reinfection and cross-infection.

(2) Nursing: Pay attention to rest, nursing and diet. If necessary, you can take a small amount of antipyretic drugs and Chinese medicine (see Bronchitis). (3) Oxygen therapy: Oxygen therapy should be given promptly to patients with severe symptoms of hypoxia or airway obstruction. The method is the same as for general pneumonia.

2. Symptomatic treatment Other symptomatic treatments are the same as those described in the bronchitis section.

(1) Expectorant: The purpose is to make sputum thinner and easier to expel. Otherwise, it is easy to increase the chance of bacterial infection, but there are few effective expectorants.

(2) Stop asthma: For patients with severe asthma, bronchodilators can be used, such as oral administration of aminophylline 4-6 mg/(kg?d) once every 6 hours; salbutamol (Albuterol) can also be used for inhalation.

3. Application of antibiotics According to the microbiological characteristics of MP, antibiotics that can hinder the synthesis of the cell wall of microorganisms, such as penicillin, are ineffective against mycoplasma. Therefore, antibiotics that can inhibit protein synthesis should be used to treat MP infection, including macrolides, tetracyclines, chloramphenicol, etc. In addition, lincomycin, clindamycin (clolindamycin), vancomycin and sulfonamides such as sulfamethoxazole (SMZ) are available for selection. Mycoplasma are sensitive to macrolide antibiotics, and erythromycin is the preferred drug.

After successful treatment, we must also take preventive measures in a timely manner, because although the course of this disease is sometimes relatively long, as long as we persist in treatment, we can still fully recover. Generally, complications rarely occur, but sometimes seizures or recurrent attacks may occur, so prognostic measures are more important.